A detailed history of Rhumbline Advisers transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Rhumbline Advisers holds 80,501 shares of PROK stock, worth $134,436. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80,501
Previous 90,393 10.94%
Holding current value
$134,436
Previous $173,000 21.39%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025

SELL
$1.46 - $2.15 $14,442 - $21,267
-9,892 Reduced 10.94%
80,501 $136,000
Q3 2024

Nov 12, 2024

BUY
$1.8 - $2.5 $25,565 - $35,507
14,203 Added 18.64%
90,393 $173,000
Q2 2024

Aug 01, 2024

BUY
$1.44 - $4.2 $8,900 - $25,960
6,181 Added 8.83%
76,190 $187,000
Q1 2024

May 09, 2024

BUY
$1.2 - $1.76 $961 - $1,409
801 Added 1.16%
70,009 $114,000
Q4 2023

Feb 08, 2024

BUY
$1.21 - $4.76 $682 - $2,684
564 Added 0.82%
69,208 $123,000
Q3 2023

Nov 09, 2023

SELL
$4.32 - $13.08 $37,925 - $114,829
-8,779 Reduced 11.34%
68,644 $314,000
Q2 2023

Aug 08, 2023

BUY
$9.0 - $13.0 $696,807 - $1.01 Million
77,423 New
77,423 $866,000

Others Institutions Holding PROK

About PROKIDNEY CORP ORD SHS CL A(CY


  • Ticker PROK
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,540,200
  • Market Cap $103M
More about PROK
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.